ACH
AGN.PRA

ArrowMark Colorado Holdings’s Allergan plc AGN.PRA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,770
Closed -$5.14M – 357
2017
Q4 		$5.14M Hold
8,770
– – 0.05% 218
2017
Q3 		$6.47M Sell
8,770
-30
-0.3% -$24.9K 0.07% 200
2017
Q2 		$7.63M Hold
8,800
– – 0.09% 176
2017
Q1 		$7.47M Hold
8,800
– – 0.1% 157
2016
Q4 		$6.71M Hold
8,800
– – 0.11% 159
2016
Q3 		$7.23M Hold
8,800
– – 0.13% 144
2016
Q2 		$7.34M Buy
+8,800
New +$7.35M 0.15% 130

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

ArrowMark Colorado Holdings's AGN.PRA Position: Q1 2018 in Review

ArrowMark Colorado Holdings sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 8,770 shares — an estimated $5.14M sold.

ArrowMark Colorado Holdings first reported a position in AGN.PRA in Q2 2016 and held it in 7 quarters. The position peaked at $7.63M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • ArrowMark Colorado Holdings reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 8,770 Allergan plc shares in Q1 2018, an estimated $5.14M.
  • ArrowMark Colorado Holdings first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
  • ArrowMark Colorado Holdings's Allergan plc position peaked at $7.63M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2018, filed 15 May 2018.